Pedro Nuno Leal Palma

USPTO Granted Patents = 14 (Patent Applications = 7)

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 4 (Patent Applications = 8)

Average Co-Inventor Count = 5.2

ph-index = 5

Forward Citations = 77(Granted Patents)

Location History:

Leca de Palmeira, PT (2013 - 2017)
Leca da Palmeira, PT (2012 - 2019)
S. Mamede do Coronado, PT (2013 - 2021)
São Mamede do Coronado, PT (2016 - 2022)

Company Filing History:

12 out of 52

Bial-portela Ca & S.a.

Bial-portela & Cª, S.a.

patents

Years Active: 2012-2024

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12129247 - Administration regime for nitrocatechols (2024-10-29),

2. 11434242 - Dopamine-b-hydroxylase inhibitors (2022-09-06),

3. 11034695 - Dopamine-β-hydroxylase inhibitors (2021-06-15),

4. 10975083 - Blood-brain barrier-penetrant dopamine-β-hydroxylase inhibitors (2021-04-13),

5. 10336740 - Nitrocatechol derivatives as COMT inhibitors (2019-07-02),

6. 10065944 - Administration regime for nitrocatechols (2018-09-04),

7. 9745290 - Dosage regimen for COMT inhibitors (2017-08-29),

8. 9550759 - Nitrocatechol derivatives as COMT inhibitors (2017-01-24),

9. 9446012 - Pharmaceutical compounds (2016-09-20),

10. 9353082 - Pharmaceutical compounds (2016-05-31),

11. 8907099 - Nitrocatechol derivatives as COMT inhibitors (2014-12-09),

12. 8536203 - Pharmaceutical compounds (2013-09-17),

13. 8524746 - Dosage regimen for COMT inhibitors (2013-09-03),

14. 8168793 - Nitrocatechol derivatives as COMT inhibitors (2012-05-01),

Title: Pedro Nuno Leal Palma: Innovator in Pharmaceutical Chemistry

Introduction

Pedro Nuno Leal Palma is a distinguished inventor based in Leca da Palmeira, Portugal. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that serve as inhibitors for various biological processes. With a total of 14 patents to his name, his work has had a notable impact on therapeutic methods.

Latest Patents

Among his latest patents is the "Administration regime for nitrocatechols," which focuses on a compound of formula (I). This invention relates to dopamine-β-hydroxylase inhibitors, encompassing several aspects: (a) compounds of formula Ia (with R1, R4 to R6, n, and A as defined) and their pharmaceutically acceptable salts or solvates; (b) pharmaceutical compositions that include such compounds; (c) the therapeutic use of these compounds; (d) methods of treatment utilizing these compounds; and (e) processes and intermediates for synthesizing these compounds.

Career Highlights

Throughout his career, Pedro has worked with notable companies in the pharmaceutical sector, including Bial-Portela & Ca S.A. and Portela & Ca., S.A. His expertise in the field has allowed him to contribute to various innovative projects and advancements in drug development.

Collaborations

Pedro has collaborated with esteemed colleagues such as Laszlo Erno Kiss and David Alexander Learmonth. These partnerships have further enriched his research and development efforts, leading to groundbreaking innovations in the pharmaceutical industry.

Conclusion

Pedro Nuno Leal Palma is a prominent figure in pharmaceutical innovation, with a strong portfolio of patents that reflect his dedication to advancing medical science. His contributions continue to influence therapeutic practices and drug development.

This text is generated by artificial intelligence and may not be accurate.